Yes and PI3K bind CD95 to signal invasion of glioblastoma
about
MicroRNA-145 targets YES and STAT1 in colon cancer cellsCD95 promotes tumour growthIn vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progressionRegulation of CD95/Fas signaling at the DISCMembrane trafficking of death receptors: implications on signallingDeath receptor-ligand systems in cancer, cell death, and inflammationThe role of CD95 and CD95 ligand in cancerThe naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathwayCD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cellsThe cleaved FAS ligand activates the Na(+)/H(+) exchanger NHE1 through Akt/ROCK1 to stimulate cell motilityThe Janus Face of Death Receptor Signaling during Tumor ImmunoeditingFas Versatile Signaling and Beyond: Pivotal Role of Tyrosine Phosphorylation in Context-Dependent Signaling and DiseasesNF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppressionJNK-induced apoptosis, compensatory growth, and cancer stem cellsTNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathwayAn Evolution-Guided Analysis Reveals a Multi-Signaling Regulation of Fas by Tyrosine Phosphorylation and its Implication in Human CancersEndothelial cell-derived CD95 ligand serves as a chemokine in induction of neutrophil slow rolling and adhesionPrecise mapping of the CD95 pre-ligand assembly domain.Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptorBlockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence.CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.The pathobiology of glioma tumorsLoss, mutation and deregulation of L3MBTL4 in breast cancers.Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.Intra- and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis.CD95 is part of a let-7/p53/miR-34 regulatory networkTargeting Fas in osteoresorptive disorders.Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasionUnderstanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer MetastasisRole of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection.Pathway inhibition: emerging molecular targets for treating glioblastoma.A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophyEnhanced contact allergen- and UVB-induced keratinocyte apoptosis in the absence of CD95/Fas/Apo-1.TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in miceTargeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studiesActivation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.
P2860
Q21142669-F2BFC5B6-FA22-4AE6-8DA2-1A51B0324671Q24602589-4EC57070-32EC-48E6-9E11-6756F5BBD62BQ24657835-6ECC83EB-A72B-4564-B128-1EAC9F86231EQ26824629-5D646764-0641-427A-8202-F6F5E2238529Q26852802-11E41EA4-6915-46FC-8F5B-E766525383CBQ26865568-BD7B877D-4C1B-4B9C-9EEC-D34CC489DD80Q26995847-61917012-EF79-40BF-9739-C8DC7A8F093EQ27321306-DD402080-A550-4A87-AC7D-F9ADC345788DQ27329081-538FAEC7-2B62-4C86-B30F-4FFEE37E5F4AQ27339583-E0380D1C-8663-496C-9DB3-7AE456CA7940Q28070036-82C1B077-4E98-461E-804B-C81CE9CF40A4Q28073778-F2342A37-CCCF-459E-B4AE-D2127A7A3BBBQ28268202-74C4A84D-7B39-498A-8B1C-D8BC8691C4BAQ28395713-2C4738FF-B6F5-459D-A750-1FC032D22330Q28580836-514C0E5E-4A67-4527-8052-C07A016C4FBDQ28603264-939578EE-BF2E-4084-ADFE-94D6E4666E9FQ28821976-C837C183-4B74-4815-A9DA-88439610A0F1Q31104620-B2D66E66-ECC6-4B8D-9AA5-60626DE43FACQ33391513-C13C0FA6-C2B2-416C-9724-BB423527FEF8Q33676412-3F661A81-81C9-4279-A5B3-B74F09B38812Q33807228-72D71E94-0B6A-4E73-9EB0-1E52EB2B0EBFQ33809161-08130931-A3C0-4D55-B22A-42FDFCC55564Q33921072-71C83A32-4339-4D86-820B-1464214CA3FBQ34105097-D518DFA9-6F2C-401E-8774-E12C20682DFCQ34253693-657122F9-5361-450C-9F10-6FF94C05CCC8Q34303359-49D6638A-A1A4-43D3-B729-34D2D8BD4F9DQ34400187-26B163B9-76F8-40BA-9DE9-5B86BA0E7B5EQ34482626-4D8D078C-D3C5-4255-BD79-8F4490413DE6Q34561691-8662156A-6D0D-476E-A432-B0EE3FF6F058Q34606869-00B74888-5588-40C2-B59E-7F9323DA195DQ34731599-AEED99C1-BCED-4E19-852C-F28C1398B463Q35006398-11A8AF4E-946A-40E7-BED5-857168EA2268Q35021359-D48ACEDB-90F0-438A-88DF-CE7825FE4FCBQ35085903-ABB3D579-CC56-477F-9EC5-780053D72C0CQ35092580-46DF3CC7-7541-4217-96DF-9D56486250D5Q35165077-8E3229A2-6814-42BC-A3B2-EEC09BBFDAC7Q35289164-BDD46F13-C991-4888-8FA5-9D2A6B1D5CA6Q35539318-99B6C84A-0154-4FB4-B610-3F98E322D786Q35570177-B305A95C-FB74-4928-8D26-B308D1D56ED8Q35783079-20BA40EF-0C1B-4991-A172-9F74F27D661D
P2860
Yes and PI3K bind CD95 to signal invasion of glioblastoma
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@ast
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@en
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@en-gb
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@nl
type
label
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@ast
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@en
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@en-gb
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@nl
prefLabel
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@ast
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@en
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@en-gb
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@nl
P2093
P50
P3181
P1433
P1476
Yes and PI3K bind CD95 to signal invasion of glioblastoma
@en
P2093
Alexandra Beisel
Ana Martin-Villalba
Andreas Kuhn
Anne Regnier-Vigouroux
Benedict Wiestler
Cecilia Zuliani
Christian Gieffers
Elisabeth Letellier
Holger Sültmann
Ignacio Sancho-Martinez
P304
P3181
P356
10.1016/J.CCR.2008.02.003
P407
P577
2008-03-01T00:00:00Z